Press Releases
-
Syngene launches platform for rapid, enhanced protein production
-
Ardena appoints Jeremie Trochu as Chief Executive Officer
Ardena has appointed Jeremie Trochu as Chief Executive Officer following the retirement of Harry Christiaens, who will remain on the company's board after 20 years of leadership. Trochu, previously with Catalent, Inc., brings extensive experience in the life sciences and CDMO industry, positioning Ardena for continued growth and international expansion.
Jun 2, 2024
-
AES Clean Technology Announces Appointment of New CEO
-
PathAI Expands Portfolio of AI-Powered Products, Announcing PathExplore™ IOP and IHC Explore™ Ahead of ASCO 2024
PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights. The product pairing provides unprecedented single-cell and spatial resolution of the tumor microenvironment from routine pathology samples to facilitate biomarker discovery and deeper understanding of treatment response for the next generation of cancer therapeutics. The expansion of the Explore™ portfolio comes at a time when AI-pathology is experiencing accelerated large-scale adoption across the diagnostic and biopharma industries.
May 28, 2024
-
Datacubed Health Sharpens Focus on eCOA and ePRO With New CEO
Datacubed Health announced the appointment of Kyle Hogan as its new chief executive officer (CEO).
May 20, 2024
-
Creative Enzymes Introduces Leaf-branch Compost Poly (ethylene terephthalate) Hydrolase for Sustainable PET Degradation
-
Creative Enzymes Introduces Recombinant Porcine Citrate Synthase with Enhanced C-His Tag for Accelerated Metabolic Research
-
ABOH Announces Winner of $150,000 Lung Cancer Research Award
We are announcing our 2024 recipient of the Julie Swedberg YOLO Cancer Research Award of $150,000. This is a new research award named in honor of Julie Swedberg, who died from lung cancer in 2023 as a 48-year-old non-smoker. Jessica Konen, PhD, of Emory University Winship Cancer Institute, will receive this national award in recognition and support of her work entitled MiR-29 as a master regulator of anti-tumor immunity. The project focuses on defining a novel mechanism of resistance to immune checkpoint inhibitor treatments in lung cancer.
May 23, 2024
-
Unraveling the Mysteries of Protein Lipidation with Creative Proteomics
-
PathAI and Aster Insights Partner to Deliver Combined AI-Derived Structured Pathology and Multimodal Real-World Data Solutions
PathAI, a global leader in AI-powered pathology, and Aster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, today announced a multi-year strategic partnership to develop curated multimodal datasets that pair PathAI’s PathExplore1 artificial intelligence (AI) tumor microenvironment (TME) quantification panel with Aster Insights’ Avatar clinical, molecular, and digital pathology imaging data. By combining their respective best-in-class platforms, PathAI and Aster Insights will be able to expedite the development of novel insights to accelerate the discovery and development of new treatments for patients with cancer.
May 22, 2024
-
Protheragen-ING Lab, a Trustworthy GLP Service Provider, Unveils Its Cutting-Edge Medical Device Services
-
CD Formulation Provides Genotoxic Impurity Testing Services to Detect and Evaluate the Potential of GIs for API and Drug Substances
-
John Potthoff Joins RQM+ as CEO
-
D'OXYVA Launches New At-Home Study to Connect More People With Revolutionary Medical Technology
D'OXYVA is thrilled to launch its nationwide at-home safety and efficacy study, open to participants across the U.S.
May 19, 2024
-
Greenphire Named 2024 “Best Overall Patient Engagement Service” by MedTech Breakthrough Awards
-
Biopharma PEG to Showcase Innovative PEG Derivatives at BIO 2024 in San Diego
Biopharma PEG, a renowned leader in the development and supply of high-quality polyethylene glycol (PEG) derivatives, is pleased to announce its participation in the BIO International Convention 2024. The event will take place from June 3-6, 2024, at the San Diego Convention Center, and attendees can visit Biopharma PEG at Booth 5102.
May 19, 2024
-
Dr. Vince Clinical Research Appoints World-Renowned Drug Developer, Clinical Pharmacologist and Neuroscientist Dr. Sheldon Preskorn as Senior VP of Neuroscience
Dr. Vince Clinical Research (DVCR) today announced the appointment of Sheldon Preskorn, M.D., as its Senior Vice President of Neuroscience.
May 7, 2024
-
Huateng Pharma Introduces Piroctone Olamine: A New Solution for Fungal Infections and Dandruff Control
Huateng Pharma, a leader in innovative pharmaceutical solutions, is excited to announce the launch of its latest product, Piroctone Olamine (CAS No. 68890-66-4).
May 19, 2024
-
Alfa Chemistry Debuts Shape Memory Alloys, Nitinol SMAs, and 3D Printing Alloys
-
Lindus Health Announces Cosmetics Clinical Trial with Acinonyx Bio to Evaluate an Alternative to Benzoyl Peroxide for Inflammatory Acne
https://www.prnewswire.com/news-releases/lindus-health-announces-cosmetics-clinical-trial-with-acinonyx-bio-to-evaluate-an-alternative-to-benzoyl-peroxide-for-inflammatory-acne-302146936.html?tc=eml_cleartime
May 15, 2024